Butsch, W. Scott
Kushner, Robert F.
Alford, Susan
Smolarz, B. Gabriel http://orcid.org/0000-0002-8591-3858
Funding for this research was provided by:
Novo Nordisk (NA)
Article History
Received: 21 October 2019
Accepted: 3 January 2020
First Online: 28 January 2020
Ethics approval and consent to participate
: Ethical approval has been waived (exempted) by Western Institutional Review Board, July 18, 2018, reference number 1–1095554-1. Prior to completing surveys, respondents provided informed consent electronically.
: Not applicable.
: Dr. Butsch is a health consultant for Novo Nordisk Inc. and on an advisory board for Rhythm Pharmaceuticals, Inc.; Dr. Kushner is on the advisory board for Novo Nordisk and WW, and is a clinical researcher for Novo Nordisk; Dr. Alford is an employee of Novo Nordisk and owns stock in Novo Nordisk.; Dr. Smolarz is an employee of Novo Nordisk and owns stock in Novo Nordisk.